These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2807560)

  • 21. Reversed-phase high-performance liquid chromatographic determination of enoxacin and 4-oxo-enoxacin in human plasma and prostatic tissue. Application to a pharmacokinetic study.
    Hamel B; Audran M; Costa P; Bressolle F
    J Chromatogr A; 1998 Jul; 812(1-2):369-79. PubMed ID: 9691332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bronchopulmonary penetration of enoxacin].
    Loos U; Sörgel F; Marklein G; Kraeft H
    Infection; 1989; 17 Suppl 1():S23-4. PubMed ID: 2807559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral enoxacin versus conventional intravenous antimicrobial therapy for chronic osteomyelitis.
    Jauregui LE; Hageage G; Martin M
    J Chemother; 1989 Jul; 1(4 Suppl):735-6. PubMed ID: 16312614
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral antibiotics for treatment of patients with chronic osteomyelitis.
    Martin ME
    Orthop Nurs; 1989; 8(3):35-8. PubMed ID: 2734030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of serum and bone concentrations of cephradine and cefuroxime by HPLC in patients undergoing hip and knee joint replacement surgery.
    Leigh DA
    J Antimicrob Chemother; 1989 Jun; 23(6):877-83. PubMed ID: 2759931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diffusion, in the bronchial mucus, of enoxacin administered by oral route in man].
    Morel C; Vergnaud M; Malbruny B; Benard Y
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):781-4. PubMed ID: 3309815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring Mn-doped ZnS quantum dots for the room-temperature phosphorescence detection of enoxacin in biological fluids.
    He Y; Wang HF; Yan XP
    Anal Chem; 2008 May; 80(10):3832-7. PubMed ID: 18407673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefoxitin antibiotic concentration in bone and synovial fluid.
    Schurman DJ; Burton DS; Kajiyama G
    Clin Orthop Relat Res; 1982 Aug; (168):64-8. PubMed ID: 7105558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibacterial activity of cefuroxime in human bone.
    Dornbusch K; Hugo H; Lidström A
    Scand J Infect Dis; 1980; 12(1):49-53. PubMed ID: 6988954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Penetration of enoxacin into middle ear effusion.
    Sundberg L; Edén T
    Acta Otolaryngol; 1990; 109(5-6):438-43. PubMed ID: 2360450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Enoxacin in the seminal fluid of prostatitis patients].
    Yasumoto R; Asakawa M
    Hinyokika Kiyo; 1988 Jun; 34(6):1101-3. PubMed ID: 3223456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of enoxacin on theophylline pharmacokinetics].
    Liu YN
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Apr; 15(2):106-8, 128. PubMed ID: 1394590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Enoxacin concentration in human prostatic tissue].
    Yasumoto R; Kobayakawa H; Asakawa M
    Hinyokika Kiyo; 1986 Oct; 32(10):1471-3. PubMed ID: 2436463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.
    Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B
    Infection; 1986; 14 Suppl 3():S203-8. PubMed ID: 3463543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effectiveness of enoxacin for the treatment of complicated urinary tract infection].
    Germinario C; Quarto M; Viggiani N; Schena FP
    Riv Eur Sci Med Farmacol; 1992; 14(5):347-51. PubMed ID: 1308966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of enoxacin in the treatment of respiratory infections.
    Scarpazza G; Della Torre F; Scaglione F; Fraschini F
    Int J Clin Pharmacol Res; 1989; 9(1):43-7. PubMed ID: 2651331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.
    Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B
    Infection; 1985; 13(5):219-24. PubMed ID: 2933340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of male genital infections with enoxacin].
    Giorgi PM; Giorgi P; Canale D; Turchi P; Poggi MS; Di Coscio M; Bartelloni M; Meschini P; Andreini F; Campa M
    Arch Ital Urol Nefrol Androl; 1989 Sep; 61(3):235-41. PubMed ID: 2529639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven days.
    Dobbs BR; Gazeley LR; Stewart IA; Edwards IR
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():61-6. PubMed ID: 3162903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further methodological improvement in antibiotic bone concentration measurements: penetration of ofloxacin into bone and cartilage.
    Wittmann DH; Kotthaus E
    Infection; 1986; 14 Suppl 4():S270-3. PubMed ID: 3469160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.